Neuigkeiten

The MAPLe is effective for OAB

25 Nov 2016

The Medical journal Neurourology and Urodynamics published a clinical study on the treatment of overactive bladder (OAB) sydrome with the MAPLe.The study, performed under 59 women with OAB, showed tha...

Lesen Sie weiter

The MAPLe® wins the award for the most innovative medical device during the MEDICA

23 Nov 2016

The MEDICA in Düsseldorf – this year from 14-18 November – is the world’s leading trade fair for the medical industry. The Netherlands Business Support Office (NBSO) organized a lunch session, ‘Neues ...

Lesen Sie weiter

Innovative developments at the IMPRESS Symposium 2016

1 Jul 2016

On Monday, 20 June 2016 Novuqare was a guest speaker at the IMPRESS Symposium 2016: Next Generation Technologies in Leeds. About 60 attendees listened attentively to the latest developments in the fie...

Lesen Sie weiter

Male, 46 years, has anal pain and difficulty emptying the bowel

17 Jun 2016

Man, 46 years old, a sedentary occupation, suffers from anal pain especially during defecation, with pain that continues for a long period thereafter. Evacuation is laborious during defecation and he ...

Lesen Sie weiter

Tendim officially became a certified MAPLe distributor!

6 Jun 2016

We are delighted that on 3 June, Tendim officially became a certified MAPLe distributor! Tendim is a Belgian supplier of medical and paramedical products for - among others - physiotherapists. Karel V...

Lesen Sie weiter

Diagnosing sacral neuro stimulation

30 Mar 2016

MAPLe case Female, 74 years of age, mother of three children. Has suffered from urinary incontinence for 15 years and fecal incontinence for the past five years. This has had a huge impact on her qual...

Lesen Sie weiter

Kontaktformular Schicken Sie eine E-Mail

Allgemeine Geschäftsbedingungen Novuqare Pelvic Health B.V.

Arbeiten bei Novuqare